Physician profile
Stephen L Miller
NPI 1851381198
$108,445.89
in general payments reported to CMS, 2019-2025
45 companies · $22K in 2025
The $22K reported for 2025 was more than what 99% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21K · 2022: $19K · 2023: $29K · 2024: $17K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Travel and Lodging: $17K · Food and Beverage: $13K · Honoraria: $3,200 · Consulting Fee: $261 · Education: $96.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,909.00 |
| Travel and Lodging | $17,276.95 |
| Food and Beverage | $12,953.43 |
| Honoraria | $3,200.00 |
| Consulting Fee | $260.85 |
| Education | $96.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $32,260.79 | 2022-2025 | |
| Scpharmaceuticals INC. | $23,441.02 | 2023-2025 | |
| Esperion Therapeutics, INC. | $12,348.65 | 2021-2025 | Nexletol |
| Daiichi Sankyo INC. | $8,575.56 | 2021-2024 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $4,918.45 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $4,902.80 | 2021-2025 | Farxiga, Wainua |
| Ancora Heart, INC. | $3,090.92 | 2023-2025 | Accucinch |
| Lilly USA, LLC | $2,275.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $1,538.18 | 2021-2025 | |
| Amgen INC. | $1,521.81 | 2021-2025 | Repatha, Repatha |
| Cvrx, INC. | $1,497.55 | 2023-2025 | Barostim Neo System |
| Medtronic, INC. | $1,494.02 | 2021-2023 | Micra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,460.75 | 2021-2025 | Lifevest |
| Pfizer INC. | $1,456.09 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $1,022.71 | 2021-2024 | Xarelto |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $968.71 | 2021-2023 | Cardiomems, Mini Trek, Nc Trek Neo |
| Heartflow, INC. | $633.23 | 2023-2025 | Ffrct |
| E.R. Squibb & Sons, L.L.C. | $528.46 | 2021-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $515.28 | 2021-2025 | Watchman Flx, Bodyguardian, General - Therapies |
| Novo Nordisk INC | $414.51 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Philips North America LLC | $399.86 | 2022-2024 | (Ck4) Mcot |
| Merck Sharp & Dohme LLC | $378.24 | 2021-2025 | Verquvo |
| Inari Medical, INC. | $340.69 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amarin Pharma, INC. | $261.24 | 2021-2023 | |
| G Medical Diagnostic Services, INC. | $244.55 | 2023-2024 | Cardiac Monitoring Suite |
| Arbor Pharmaceuticals, INC. | $231.93 | 2021-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $194.14 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $164.87 | 2022-2024 | |
| Shockwave Medical, INC | $152.00 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Alnylam Pharmaceuticals INC. | $141.98 | 2025 | Onpattro, Amvuttra |
| Silk Road Medical, INC. | $134.10 | 2022 | |
| Itamar Medical INC | $124.19 | 2023 | Watchpatone |
| Kowa Pharmaceuticals America, INC. | $110.97 | 2021 | |
| Azurity Pharmaceuticals, INC. | $110.43 | 2023 | Edarbyclor, Edarbi |
| Biotronik INC. | $107.19 | 2021 | |
| Penumbra, INC. | $88.25 | 2024 | Indigo System |
| Actelion Pharmaceuticals US, INC. | $82.56 | 2023-2025 | Uptravi, Opsumit |
| Edwards Lifesciences Corporation | $79.69 | 2024 | |
| Baxter Healthcare | $72.04 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Kiniksa Pharmaceuticals, Ltd. | $41.55 | 2023 | Arcalyst |
| Chiesi USA, INC. | $29.24 | 2025 | Juxtapid |
| Mallinckrodt Hospital Products INC. | $27.73 | 2022 | |
| Altathera Pharmaceuticals LLC | $24.61 | 2023 | Sotalol Hydrochloride |
| Atricure, INC. | $20.57 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $18.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.